RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
156 hedge funds and large institutions have $1.02B invested in Revance Therapeutics, Inc. in 2022 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 46 increasing their positions, 59 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
22% less repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 59
Holders
156
Holding in Top 10
2
Calls
$27.5M
Puts
$9.97M
Top Buyers
| 1 | +$11.8M | |
| 2 | +$7.66M | |
| 3 | +$6.29M | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$5.18M |
| 5 |
Jennison Associates
New York
|
+$4.64M |
Top Sellers
| 1 | -$13.5M | |
| 2 | -$7.06M | |
| 3 | -$3.3M | |
| 4 |
Goldman Sachs
New York
|
-$2.91M |
| 5 |
JPMorgan Chase & Co
New York
|
-$2.13M |